Bryn Mawr Capital Management LLC Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Bryn Mawr Capital Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,843 shares of the healthcare conglomerate’s stock after selling 4,412 shares during the period. Bryn Mawr Capital Management LLC’s holdings in UnitedHealth Group were worth $17,120,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the third quarter valued at approximately $37,000. DecisionPoint Financial LLC boosted its holdings in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at $55,000. Finally, Legacy Investment Solutions LLC bought a new position in UnitedHealth Group during the third quarter valued at $57,000. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts recently commented on UNH shares. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $510.75 on Thursday. The firm has a market capitalization of $470.03 billion, a P/E ratio of 32.95, a PEG ratio of 1.43 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average price of $520.62 and a 200 day moving average price of $561.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company earned $5.83 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.